Information Provided By: 
Fly News Breaks for July 18, 2017
PBYI
Jul 18, 2017 | 07:50 EDT
Credit Suisse analyst Alethia Young raised her price target for Puma Biotechnology to $118 from $90, saying she is moving her base case to an M&A DCF because she thinks that this remains the likely outcome from here. The analyst reiterates an Outperform rating on the shares.
News For PBYI From the Last 2 Days
There are no results for your query PBYI
